Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
31.07.2024 18:36:30

EQS-Adhoc: CompuGroup Medical SE & Co. KGaA appoints Prof. Dr. Daniel Gotthardt as new CEO

EQS-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Personnel
CompuGroup Medical SE & Co. KGaA appoints Prof. Dr. Daniel Gotthardt as new CEO

31-Jul-2024 / 18:36 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


CompuGroup Medical SE & Co. KGaA appoints Prof. Dr. Daniel Gotthardt as new CEO

Koblenz, Germany. The general partner of CompuGroup Medical SE & Co. KGaA (the “Company”) (ISIN: DE000A288904 | WKN: A28890) announces that the Administrative Board of CompuGroup Medical Management SE and CEO Michael Rauch decided today in mutual agreement to terminate his contract prematurely as of August 31, 2024, including resignation from his position as Managing Director and member of the Administrative Board of CompuGroup Medical Management SE as well as of the Joint Committee of the Company.

Effective as of September 1, 2024, the Administrative Board of CompuGroup Medical Management SE appoints Prof. (apl.) Dr. med. Daniel Gotthardt as Managing Director and CEO. Daniel Gotthardt has been Senior Vice President and Chief Medical Officer of the Company since the beginning of 2023. He has also been a member of the Supervisory Board of former CompuGROUP Holding AG and CompuGroup Medical SE since 2003, and has been a member of the Administrative Board of CompuGroup Medical Management SE since 2020.

 

 

 



End of Inside Information

31-Jul-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)160 3630362
Fax: +49 (0)261 8000 3200
E-mail: investor@cgm.com
Internet: www.cgm.com
ISIN: DE000A288904
WKN: A28890
Indices: SDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1958515

 
End of Announcement EQS News Service

1958515  31-Jul-2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1958515&application_name=news&site_id=finanzen_net~~~069d1026-6a45-454f-953c-2a2c4451f1d6

Analysen zu CompuGroup Medical SE & Co. KGaAmehr Analysen

08.11.24 CompuGroup Medical Buy Baader Bank
08.11.24 CompuGroup Medical Hold Deutsche Bank AG
08.11.24 CompuGroup Medical Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
07.11.24 CompuGroup Medical Buy Warburg Research
07.11.24 CompuGroup Medical Buy Baader Bank
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

CompuGroup Medical SE & Co. KGaA 15,52 2,04% CompuGroup Medical SE & Co. KGaA